2013
DOI: 10.1002/prp2.1
|View full text |Cite
|
Sign up to set email alerts
|

α1D‐Adrenoceptors are responsible for the high sensitivity and the slow time‐course of noradrenaline‐mediated contraction in conductance arteries

Abstract: The objective of this study was to determine whether the different time-course characteristics of α1-adrenoceptor-mediated contraction in arteries can be related to the subtypes involved. Contractile responses to noradrenaline (NA) were compared with inositol phosphate accumulation and extracellular signal-regulated kinase (ERK)1/2 phosphorylation after α1-agonist stimuli in the same vessels in the presence or absence of α1-antagonists in rat or in α1-subtype knockout (KO) mice. Aorta, where α1D-AR is the main… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
6
0

Year Published

2015
2015
2019
2019

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 8 publications
(9 citation statements)
references
References 48 publications
1
6
0
Order By: Relevance
“…The present results provide evidence of the importance of the modulatory α 1A ‐adrenoceptor/nNOS pathway in aorta where the α 1D ‐adrenoceptor subtype, sensitive to low levels of circulating catecholamines (Flacco et al , ), is primarily responsible for α 1 ‐adrenoceptor‐mediated vasoconstriction. In this vessel, the α 1A ‐adrenoceptor subtype, located in endothelial cells (Ciccarelli et al , ), regulates an nNOS‐dependent desensitization pathway that potentially attenuates vasoconstriction during excessive (intense or sustained) stimulation by circulating catecholamines.…”
Section: Discussionsupporting
confidence: 52%
See 2 more Smart Citations
“…The present results provide evidence of the importance of the modulatory α 1A ‐adrenoceptor/nNOS pathway in aorta where the α 1D ‐adrenoceptor subtype, sensitive to low levels of circulating catecholamines (Flacco et al , ), is primarily responsible for α 1 ‐adrenoceptor‐mediated vasoconstriction. In this vessel, the α 1A ‐adrenoceptor subtype, located in endothelial cells (Ciccarelli et al , ), regulates an nNOS‐dependent desensitization pathway that potentially attenuates vasoconstriction during excessive (intense or sustained) stimulation by circulating catecholamines.…”
Section: Discussionsupporting
confidence: 52%
“…It is well known that among the three α 1 ‐adrenoceptor subtypes present in the aorta, α 1D is the main subtype involved in contractile responses, the α 1A subtype participates but has a minor role, whereas the α 1B ‐adrenoceptor has not been implicated in the control of vascular tone so far (Flacco et al , ). A selective α 1D ‐adrenoceptor antagonist (BMY 7378) did not affect, while a selective α 1A ‐adrenoceptor antagonist (5‐methylurapidil) prevented the desensitization process, suggesting that it is mediated by activation of α 1A ‐adrenoceptors.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The α 1Aadrenoceptors predominate in resistance arteries such as the small mesenteric artery (Marti et al, 2005;Methven, McBride, Wallace, & McGrath, 2009;Nourian et al, 2008;Philipp & Hein, 2004) and distributing arteries such as the renal (Hrometz et al, 1999) Gisbert et al, 2000;Hussain & Marshall, 1997;Marti et al, 2005;Methven, Simpson, & McGrath, 2009;Nourian et al, 2008;Piascik et al, 1995;Rudner et al, 1999). This differential distribution of α 1A -adrenoceptors indicates physiological relevance; the dominant α 1Dadrenoceptors in conductance arteries result in high sensitivity to catecholamines, and the activation of this subtype leads to persistent vasoconstriction that tends to continue even after agonist removal, preventing sudden changes in the vessel calibre during variations in the circulating levels of catecholamines (Flacco et al, 2013;Gisbert et al, 2000;Noguera et al, 1996;Ziani et al, 2002).…”
Section: α 1 -Adrenoceptors In Arteriesmentioning
confidence: 99%
“…We could not contribute to the argument about whether the subtypes were differently involved in agonist-induced internalisation because our antagonist ligand, at any concentration that is useful for receptor localisation, blocks responses to even high concentrations of phenylephrine . However, by labeling the surface receptors with an antibody that only fluoresces once internalised, colleagues were able to show that both α 1A-and α1B-subtypes could be internalised after activation by high concentrations of phenylephrine with only a small difference in time course (Flacco et al, 2013;Perez-Aso et al, 2013;Segura et al, 2013).…”
Section: Figurementioning
confidence: 99%